Breiter Capital Management »

ResMed shares owned by Breiter Capital Management

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Breiter Capital Management from 13F filings

Historical chart of Breiter Capital Management investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Breiter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Breiter Capital Management

Quarter filed Position value Share count Share price at filing
2022-03-31 $493k 2.0k 242.74
2021-12-31 $529k 2.0k 260.46
2021-09-30 $535k 2.0k 263.42
2021-06-30 $506k 2.1k 246.35
2020-12-31 $437k 2.1k 212.76

More positions owned by Breiter Capital Management

Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Global X Fds Glbl X Mlp Etf (MLPA)
Microsoft Corporation (MSFT)
Lam Research Corporation (LRCX)
First Tr Exchange-traded Cap Strength Etf (FTCS)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Iron Mountain (IRM)
First Tr Sml Cp Core Alpha F Com Shs (FYX)
Home Depot (HD)
Abbvie (ABBV)
UnitedHealth (UNH)
4068594 Enphase Energy (ENPH)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Breiter Capital Management

Top funds holding ResMed

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Goldman Sachs Group
Select Equity
Charles Schwab Investment Management
Greenvale Capital
Dimensional Fund Advisors
Jpmorgan Chase & Co

View all funds holding ResMed